Everolimus combined with endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: A retrospective study.
文献类型：期刊论文
| 作者 | Shen, Xia-Bo; Li, Guang-Liang; Zheng, Ya-Bing; Chen, Zhan-Hong; Cao, Wen-Ming; Shao, Xi-Ying; Wang, Xiao-Jia |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2021-05-20 |
| 卷号 | 39 |
| ISSN号 | 0732-183X |
| DOI | 10.1200/JCO.2021.39.15_suppl.e13023 |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000708120300140 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/126514]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Zhejiang Canc Hosp, Hangzhou, Peoples R China 2.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China |
| 推荐引用方式 GB/T 7714 | Shen, Xia-Bo,Li, Guang-Liang,Zheng, Ya-Bing,et al. Everolimus combined with endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: A retrospective study.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39. |
| APA | Shen, Xia-Bo.,Li, Guang-Liang.,Zheng, Ya-Bing.,Chen, Zhan-Hong.,Cao, Wen-Ming.,...&Wang, Xiao-Jia.(2021).Everolimus combined with endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: A retrospective study..JOURNAL OF CLINICAL ONCOLOGY,39. |
| MLA | Shen, Xia-Bo,et al."Everolimus combined with endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: A retrospective study.".JOURNAL OF CLINICAL ONCOLOGY 39(2021). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。